Bayer eyes launch of menopause relief, heart drugs this year
Bayer said on Tuesday it was preparing market launches this year of two new drugs that could each have annual peak sales of ...
Life Sciences IP Review1d
‘Always new twists’: Bayer legal team on defending a $4bn drug
With billions in revenue at stake, the pharma giant has a 27-country parallel litigation effort to protect its blockbuster ...
China Daily Global Edition1d
US pharmaceutical giant opens R&D center in Beijing
BEIJING - US pharmaceutical giant Pfizer's new research and development (R&D) center officially opened at BioPark in the ...
AgWeb4d
Bayer President Views Agriculture Through a Lens of Optimism
Brian Naber says growing up in a farming family in southwest Minnesota helped prepare him for the rigors of leading the ...
Elliott gauged investor interest in Bayer’s consumer health business, FT says
Elliott Management held talks with private equity groups in recent months to gauge interest in buying Bayer’s (BAYRY) consumer health business, ...
Bayer acquires rights in Puhe BioPharma cancer drug candidate
Bayer said on Wednesday it struck a global licence agreement for an experimental oral cancer drug for targeted therapies with ...
Monsanto Owner Bayer (BAYRY) Slumps on $2B Roundup Penalty after Georgia Court Ruling
Bayer (BAYRY) stock fell after the German company was ordered by a Georgia jury to pay $2.1 billion to a plaintiff who claimed his cancer was ...
Bayer hit with $2 billion Roundup verdict in Georgia cancer case
Bayer was ordered by a jury in the U.S. state of Georgia to pay about $2.1 billion to a plaintiff who claimed the company's ...
Bayer Welcomes New Law in U.S. State to Better Shield It Against Glyphosate Litigation
FRANKFURT (Reuters) -Bayer said on Monday that it welcomed a new law about to be passed in the U.S. state of Georgia to ...